| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €174.7M | +3.0% |
| Gross Profit | €67.5M | −5.0% |
| EBITDA | -€60.3M | −283.2% |
| Net Income | — | — |
| Diluted EPS | -€0.68 | — |
| Free Cash Flow | -€57.3M | — |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 50.78% | 46.01% | 10.20% | 34.37% | 41.89% | 38.66% | 42% | 53% | |
| Operating Margin | −49.96% | −17.64% | −31.40% | −53.40% | 7.86% | −46.98% | 42% | 13% | |
| EBITDA Margin | −41.08% | −13.53% | −25.58% | −41.96% | 19.41% | −34.53% | 42% | 13% | |
| NOPAT Margin | −39.47% | −13.93% | −24.80% | −42.19% | 6.21% | −37.12% | 42% | 10% | |
| Net Margin | −49.96% | −17.64% | — | — | — | — | — | — | |
| FCF Margin | 107.69% | −4.40% | −76.00% | −141.16% | −47.81% | −32.81% | 58% | 12% | |
| FCFE Margin | 133.31% | −4.72% | −65.61% | −89.75% | −50.02% | −131.08% | 8% | 7% | |
| OCF Margin | 124.85% | 22.09% | −67.91% | −131.90% | −39.64% | −30.28% | 58% | 14% | |
| Gross Profitability | 12.47% | 19.60% | 5.93% | 11.48% | 14.21% | 16.93% | 75% | 35% | |
| Capex Intensity | 17.16% | 26.50% | 8.09% | 9.26% | 8.18% | 2.53% | 8% | 31% | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 3 ratios | |||||||||
| ▸Earnings quality · 4 ratios | |||||||||
| ▸Liquidity & coverage · 9 ratios | |||||||||
| ▸Leverage · 9 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Capital allocation · 1 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | €110.3M | €348.1M | €361.3M | €153.7M | €169.6M | €174.7M |
| YoY % | +215.5% | +3.8% | -57.5% | +10.3% | +3.0% | |
| Cost of Revenue | €54.3M | €187.9M | €324.4M | €100.9M | €98.5M | €107.1M |
| YoY % | +246.1% | +72.6% | -68.9% | -2.3% | +8.7% | |
| R&D Expense | €84.5M | €173.3M | €104.9M | €59.9M | €74.1M | €85.3M |
| YoY % | +105.2% | -39.5% | -42.9% | +23.8% | +15.1% | |
| Selling & Marketing Expense | €18.3M | €23.6M | — | — | — | — |
| YoY % | +29.5% | |||||
| SG&A Expense | €27.5M | €47.6M | €34.1M | €47.8M | €42.8M | €37.3M |
| YoY % | +72.9% | -28.4% | +40.3% | -10.6% | -12.7% | |
| Total Operating Expenses | €184.6M | €432.5M | €486.9M | €257.3M | €267.8M | €267.1M |
| YoY % | +134.3% | +12.6% | -47.2% | +4.1% | -0.2% | |
| Operating Income | -€55.1M | -€61.4M | -€113.4M | -€82.1M | €13.3M | -€82.1M |
| Interest Expense | €10.7M | €17.0M | €19.1M | €23.3M | €24.0M | €41.9M |
| YoY % | +58.0% | +12.3% | +22.4% | +2.8% | +74.7% | |
| Interest & Investment Income | €516,000 | €249,000 | €260,000 | €1.2M | €2.4M | €2.6M |
| YoY % | -51.7% | +4.4% | +365.4% | +95.2% | +11.9% | |
| Equity Method Income | -€133,000 | -€5,000 | €9,000 | €0 | €0 | — |
| YoY % | -100.0% | |||||
| Pretax Income | -€65.3M | -€70.0M | -€144.8M | -€98.6M | -€11.5M | -€114.1M |
| Income Tax | -€909,000 | €3.4M | -€1.5M | €2.8M | €761,000 | €1.1M |
| YoY % | -72.8% | +41.0% | ||||
| Net Income (incl. NCI) | -€64.4M | -€73.4M | -€143.3M | -€101.4M | -€12.2M | -€115.2M |
| Net Income | -€55.1M | -€61.4M | — | — | — | — |
| Net Income to Common | -€64.4M | -€73.4M | -€143.3M | -€101.4M | -€12.2M | -€115.2M |
| EPS (Basic) | -€0.71 | -€0.75 | -€1.24 | -€0.73 | -€0.08 | -€0.68 |
| EPS (Diluted) | -€0.71 | -€0.75 | -€1.24 | -€0.73 | -€0.08 | -€0.68 |
| Weighted Avg Shares (Basic) | 90.8M | 97.6M | 115.5M | 138.6M | 145.7M | 168.2M |
| YoY % | +7.6% | +18.3% | +20.0% | +5.1% | +15.4% | |
| Weighted Avg Shares (Diluted) | 90.8M | 97.6M | 115.5M | 138.6M | 145.7M | 168.2M |
| YoY % | +7.6% | +18.3% | +20.0% | +5.1% | +15.4% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
